Decoding spontaneous thoughts from the brain via machine learning

by Institute for Basic ScienceFigure 1. Predictive modeling analysis pipelineFirst, the data was independently segmented into quintiles (5 levels) for self-relevance and valence based on particip

Updated on: April 28,2024

Decoding spontaneous thoughts from the brain via machine learning

by Institute for Basic ScienceFigure 1. Predictive modeling analysis pipelineFirst, the data was independently segmented into quintiles (5 levels) for self-relevance and valence based on particip

Updated on:April 28,2024

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Updated on: March 24,2024

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Updated on:March 24,2024

Family caregivers find support on #dementia TikTok

by Kate WellsCredit: Unsplash/CC0 Public DomainIt all changed on a Saturday night in New York City in 2016. Jacquelyn Revere was 29 and headed out to attend a friend's comedy show. She was on the

Updated on: June 20,2024

Family caregivers find support on #dementia TikTok

by Kate WellsCredit: Unsplash/CC0 Public DomainIt all changed on a Saturday night in New York City in 2016. Jacquelyn Revere was 29 and headed out to attend a friend's comedy show. She was on the

Updated on:June 20,2024

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on: March 30,2024

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on:March 30,2024

First U.S. clinical trial using adult allogeneic stem cells to treat Alzheimer's disease

by Emory UniversityA new study to assess the safety, tolerability and preliminary efficacy of allogeneic stem cells in persons with mild to moderate dementia due to Alzheimer's disease (AD) i

Updated on: March 07,2024

First U.S. clinical trial using adult allogeneic stem cells to treat Alzheimer's disease

by Emory UniversityA new study to assess the safety, tolerability and preliminary efficacy of allogeneic stem cells in persons with mild to moderate dementia due to Alzheimer's disease (AD) i

Updated on:March 07,2024

A new book by neuroscientist offers strategies for reducing the risk of Alzheimer's disease

by Julie Cohen,University of California - Santa BarbaraA brain illustration. Credit: UCSBDiet, exercise, a good night's sleep—all sound recommendations for mitigating one's risk for ever

Updated on: February 27,2024

A new book by neuroscientist offers strategies for reducing the risk of Alzheimer's disease

by Julie Cohen,University of California - Santa BarbaraA brain illustration. Credit: UCSBDiet, exercise, a good night's sleep—all sound recommendations for mitigating one's risk for ever

Updated on:February 27,2024

Alzheimer's disease: Sex affects tau accumulation in the brain

by Society of Nuclear Medicine and Molecular ImagingSex Modulates the ApoE ε4 Effect on 18F-AV-1451 Tau PET. Credit: Paranjpe M, Liu M, Paranjpe I, et al.The strongest genetic risk factor for Alzheime

Updated on: April 10,2024

Alzheimer's disease: Sex affects tau accumulation in the brain

by Society of Nuclear Medicine and Molecular ImagingSex Modulates the ApoE ε4 Effect on 18F-AV-1451 Tau PET. Credit: Paranjpe M, Liu M, Paranjpe I, et al.The strongest genetic risk factor for Alzheime

Updated on:April 10,2024

Study finds high prevalence of hidden brain changes in people with heart disease

byGeorge Institute for Global HealthCredit: Pixabay/CC0 Public DomainA new analysis involving over 13,000 people has found changes to blood vessels in the brain that can increase the risk of str

Updated on: March 28,2024

Study finds high prevalence of hidden brain changes in people with heart disease

byGeorge Institute for Global HealthCredit: Pixabay/CC0 Public DomainA new analysis involving over 13,000 people has found changes to blood vessels in the brain that can increase the risk of str

Updated on:March 28,2024

Eating mushrooms may reduce the risk of cognitive decline

by National University of SingaporeA six-year study, led by Assistant Professor Lei Feng (left) from the National University of Singapore, found that seniors who ate more than 300 grams of cooked

Updated on: May 06,2024

Eating mushrooms may reduce the risk of cognitive decline

by National University of SingaporeA six-year study, led by Assistant Professor Lei Feng (left) from the National University of Singapore, found that seniors who ate more than 300 grams of cooked

Updated on:May 06,2024

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on: March 30,2024

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on:March 30,2024

In quiet debut, Alzheimer's drug finds questions, skepticism

by Tom MurphyThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. The first new Alzheimer's treatment in more than 20 years was hailed as a breakt

Updated on: April 23,2024

In quiet debut, Alzheimer's drug finds questions, skepticism

by Tom MurphyThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. The first new Alzheimer's treatment in more than 20 years was hailed as a breakt

Updated on:April 23,2024

Alzheimer's disease risk gene APOE4 impairs function of brain immune cells

by University of Eastern FinlandThe induced pluripotent stem cell (iPSC) -derived microglia demonstrate that apolipoprotein E4 (APOE4) has a profound impact on several functions of human brain im

Updated on: April 08,2024

Alzheimer's disease risk gene APOE4 impairs function of brain immune cells

by University of Eastern FinlandThe induced pluripotent stem cell (iPSC) -derived microglia demonstrate that apolipoprotein E4 (APOE4) has a profound impact on several functions of human brain im

Updated on:April 08,2024